The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 21, 2020

Filed:

Feb. 19, 2016
Applicants:

Abivax, Paris, FR;

Centre National DE LA Recherche Scientifique, Paris, FR;

Institut Curie, Paris, FR;

Universite DE Montpellier, Montpellier, FR;

Inventors:

Didier Scherrer, Castelnau Le Lez, FR;

Aude Garcel, Le Cres, FR;

Noelie Campos, Le Cres, FR;

Jamal Tazi, Clapiers, FR;

Audrey Vautrin, Castelnau Le Lez, FR;

Florence Mahuteau, Saint Remy les Chevreuses, FR;

Romain Najman, L'Hay-les-Roses, FR;

Pauline Fornarelli, Villebon Sur Yvette, FR;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56983 (2013.01); G01N 2333/16 (2013.01); G01N 2469/10 (2013.01); G01N 2500/02 (2013.01); G01N 2500/10 (2013.01);
Abstract

The present invention relates to a method for screening a compound useful for treating or preventing a viral infection or a virus-related condition in an individual, comprising at least the steps of: a) determining the ability of a candidate compound to promote the interaction between CBP20 and CBP80 in a sample, and b) selecting the candidate compound that is determined to promote said interaction at step a). The present invention further relates to a method for screening a compound useful for treating or preventing a viral infection or virus-related condition in an individual, comprising at least the steps of: a) determining the ability of a candidate compound to interact with CBP20 or CBP80 in a sample, and b) selecting the candidate compound that is determined to interact with CBP20 or CBP80 at step a).


Find Patent Forward Citations

Loading…